Literature DB >> 7531193

Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. I. Taxonomy, production, isolation and biological activity.

C H Lee1, S Kim, B Hyun, J W Suh, C Yon, C Kim, Y Lim, C Kim.   

Abstract

Cepacidine A is a potent antifungal antibiotic produced by Pseudomonas cepacia AF 2001. The compound was isolated from the fermentation broth with 1 vol isopropyl alcohol, followed by the collection of the precipitation formed upon concentration of the extract. Purification was effected by chromatography on Diaion HP-20, alumina and reversed phase C18 followed by TLC on silica gel. These techniques afforded the two closely related compounds, cepacidine A1 and cepacidine A2. A mixture of these two compounds called capacidine A, showed high in vitro antifungal activity against the various animal and plant pathogenic fungi. The activity was diminished by the presence of serum. No antibacterial activity was demonstrable.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531193     DOI: 10.7164/antibiotics.47.1402

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  18 in total

1.  Potential of Burkholderia seminalis TC3.4.2R3 as Biocontrol Agent Against Fusarium oxysporum Evaluated by Mass Spectrometry Imaging.

Authors:  Francisca Diana da Silva Araújo; Welington Luiz Araújo; Marcos Nogueira Eberlin
Journal:  J Am Soc Mass Spectrom       Date:  2017-02-13       Impact factor: 3.109

2.  Characterization of genes involved in biosynthesis of a novel antibiotic from Burkholderia cepacia BC11 and their role in biological control of Rhizoctonia solani.

Authors:  Y Kang; R Carlson; W Tharpe; M A Schell
Journal:  Appl Environ Microbiol       Date:  1998-10       Impact factor: 4.792

Review 3.  Antifungal peptides: novel therapeutic compounds against emerging pathogens.

Authors:  A J De Lucca; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 4.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

Review 5.  Nonribosomal peptides and polyketides of Burkholderia: new compounds potentially implicated in biocontrol and pharmaceuticals.

Authors:  Qassim Esmaeel; Maude Pupin; Philippe Jacques; Valérie Leclère
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-25       Impact factor: 4.223

6.  Burkholderia as a Source of Natural Products.

Authors:  Sylvia Kunakom; Alessandra S Eustáquio
Journal:  J Nat Prod       Date:  2019-07-11       Impact factor: 4.050

7.  Isolation and characterization of antifungal substances from Burkholderia sp. culture broth.

Authors:  Sopheareth Mao; Seung-Je Lee; Hoon Hwangbo; Yong-Woong Kim; Keun-Hyung Park; Gyu-Suk Cha; Ro-Dong Park; Kil-Yong Kim
Journal:  Curr Microbiol       Date:  2006-10-19       Impact factor: 2.188

8.  Occidiofungin's chemical stability and in vitro potency against Candida species.

Authors:  Dayna Ellis; Jiten Gosai; Charles Emrick; Rachel Heintz; Lanette Romans; Donna Gordon; Shi-En Lu; Frank Austin; Leif Smith
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

9.  Virgicin, a novel lanthipeptide from Virgibacillus sp. strain AK90 exhibits inhibitory activity against Gram-positive bacteria.

Authors:  Vasundhera Gupta; Shelley Sardul Singh; Chandni Sidhu; Vishakha Grover; Anil Kumar Pinnaka; Suresh Korpole
Journal:  World J Microbiol Biotechnol       Date:  2019-08-20       Impact factor: 3.312

Review 10.  The Mechanistic Targets of Antifungal Agents: An Overview.

Authors:  Tryphon K Mazu; Barbara A Bricker; Hernan Flores-Rozas; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.